Dr Raminderpal Singh speaks with Dr Srijit Seal about why specialised AI agents are outperforming general-purpose models in ...

Many promising therapies fail because preclinical models do not fully capture the complexity of the human heart. A new review ...

An AI-assisted drug discovery platform using transfer learning has identified a promising gp130 inhibitor for colorectal ...

Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...

Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...

One, an integrated platform combining high-throughput ADME testing with AI-powered human pharmacokinetic projections.

NIH researchers have identified the intracellular signalling pathways through which semaglutide and other GLP-1 receptor agonists induce weight loss, revealing why patient responses vary and treatment ...

German researchers have used cerebral organoids to investigate how the epilepsy medication valproate interferes with early ...

Genome-wide association studies have linked thousands of genetic variants to disease, yet most remain disconnected from drug-relevant biology. Neville Sanjana, Professor at New York University and ...

A novel 3D-printed confined culture system has enabled researchers to generate larger, more advanced human gastrointestinal ...

Researchers have identified metabolic vulnerabilities in Fibrolamellar cancer, a rare liver malignancy affecting adolescents and young adults, using functional profiling and mass spectrometry. The ...

Tau tangles are a hallmark of Alzheimer's disease and related disorders, but evidence suggests the real damage may come from ...